|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.120 USD | -.--% |
|
-.--% | -22.76% |
| Jul. 01 | AB Science, successful private placement |  |
| Jun. 30 | AB Science S.A. announced that it has received ?2.294 million in funding | CI |
Last Transcript: AB Science
| 3 months | -22.76% | ||
| 6 months | -22.76% | ||
| Current year | -22.76% |
| Current year | 1.12 |  | 1.37 |
| 1 year | 1.12 | | 1.45 |
| 3 years | 0 | | 4.46 |
| 5 years | 0 | | 18.78 |
| 10 years | 0 | | 26.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alain Moussy
CEO | Chief Executive Officer | - | 2001-07-10 |
Laurent Guy
DFI | Director of Finance/CFO | - | 2009-11-19 |
| Chief Tech/Sci/R&D Officer | - | 2018-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Alain Moussy
CHM | Chairman | - | 2001-07-10 |
Patrick Moussy
BRD | Director/Board Member | - | 2011-09-19 |
| Director/Board Member | 64 | 2021-06-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 70.75M | |
| +3.34% | +0.70% | +60.09% | +13.32% | 320B | |
| -1.25% | 0.00% | +30.92% | -1.55% | 72.44B | |
| +3.17% | +5.99% | +47.13% | +115.43% | 9.42B | |
| +1.24% | +4.51% | +5.99% | +0.26% | 8.65B | |
| +8.48% | +25.95% | +25.73% | +38.15% | 4.52B | |
| -0.46% | +3.98% | -5.69% | +3.61% | 4.41B | |
| +0.43% | +6.02% | -33.90% | +24.44% | 3.43B | |
| +1.35% | +2.58% | +50.25% | +60.70% | 2.79B | |
| -1.28% | +7.61% | +15.27% | -23.79% | 2.19B | |
| Average | +1.50% | +3.10% | +21.75% | +25.62% | 47.54B | |
| Weighted average by Cap. | +2.47% | +2.85% | +51.68% | +13.16% |
Employees
31
Sector
Pharmaceuticals
- Stock Market
- Stocks
- AB Stock
- ABSCF Stock
Select your edition
All financial news and data tailored to specific country editions
